Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Smit

Showing results (431-440 of 692) with videos related to

Pageof 70
Sort By:
Journal of Clinical Pathology|May 3, 2002
Multidrug resistance related molecules in human and murine lungG L Scheffer, A C L M Pijnenborg, E F Smit, et al.
Plos One|October 17, 2019
Clonality analysis of pulmonary tumors by genome-wide copy number profilingJulien P L Vincenten, Hendrik F van Essen, Birgit I Lissenberg-Witte, et al.
Journal of Cancer Research and Clinical Oncology|March 7, 2015
Adherence, exposure and patients' experiences with the use of erlotinib in non-small cell lung cancerLonneke Timmers, Christel C L M Boons, J Moes-Ten Hove, et al.
Archives of Pathology & Laboratory Medicine|September 19, 2024
Analytical and Clinical Validation of the Oncomine Dx Target Test to Assess HER2 Mutation Status in Tumor Tissue Samples From Patients With Non-Small Cell Lung Cancer Treated With Trastuzumab Deruxtecan in the DESTINY-Lung01 and DESTINY-Lung02 StudiesZhenhao Qi, Thomas Ha, Wenqin Feng, et al.
The Journal of Nutrition|August 27, 2010
Oral nutritional supplements containing (n-3) polyunsaturated fatty acids affect the nutritional status of patients with stage III non-small cell lung cancer during multimodality treatmentBarbara S van der Meij, Jacqueline A E Langius, Egbert F Smit, et al.
Virchows Archiv : an International Journal of Pathology|October 31, 2006
Diminished expression of multidrug resistance-associated protein 1 (MRP1) in bronchial epithelium of COPD patientsMargaretha van der Deen, Hendrik Marks, Brigitte W M Willemse, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 18, 2014
Parametric methods for quantification of 18F-FAZA kinetics in non-small cell lung cancer patientsEline E Verwer, Idris Bahce, Floris H P van Velden, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 28, 2016
Accuracy and Precision of Partial-Volume Correction in Oncological PET/CT StudiesMatthijs C F Cysouw, Gerbrand Maria Kramer, Otto S Hoekstra, et al.
Lung Cancer (Amsterdam, Netherlands)|November 8, 2017
Continued use of afatinib with the addition of cetuximab after progression on afatinib in patients with EGFR mutation-positive non-small-cell lung cancer and acquired resistance to gefitinib or erlotinibLeora Horn, Scott Gettinger, D Ross Camidge, et al.
The European Respiratory Journal|January 25, 2008
Right ventricular contractility in systemic sclerosis-associated and idiopathic pulmonary arterial hypertensionM J Overbeek, J-W Lankhaar, N Westerhof, et al.
Pageof 70

Showing results (431-440 of 692) with videos related to

Sort By:
Pageof 70
Journal of Clinical Pathology|May 3, 2002
Multidrug resistance related molecules in human and murine lungG L Scheffer, A C L M Pijnenborg, E F Smit, et al.
Plos One|October 17, 2019
Clonality analysis of pulmonary tumors by genome-wide copy number profilingJulien P L Vincenten, Hendrik F van Essen, Birgit I Lissenberg-Witte, et al.
Journal of Cancer Research and Clinical Oncology|March 7, 2015
Adherence, exposure and patients' experiences with the use of erlotinib in non-small cell lung cancerLonneke Timmers, Christel C L M Boons, J Moes-Ten Hove, et al.
Archives of Pathology & Laboratory Medicine|September 19, 2024
Analytical and Clinical Validation of the Oncomine Dx Target Test to Assess HER2 Mutation Status in Tumor Tissue Samples From Patients With Non-Small Cell Lung Cancer Treated With Trastuzumab Deruxtecan in the DESTINY-Lung01 and DESTINY-Lung02 StudiesZhenhao Qi, Thomas Ha, Wenqin Feng, et al.
The Journal of Nutrition|August 27, 2010
Oral nutritional supplements containing (n-3) polyunsaturated fatty acids affect the nutritional status of patients with stage III non-small cell lung cancer during multimodality treatmentBarbara S van der Meij, Jacqueline A E Langius, Egbert F Smit, et al.
Virchows Archiv : an International Journal of Pathology|October 31, 2006
Diminished expression of multidrug resistance-associated protein 1 (MRP1) in bronchial epithelium of COPD patientsMargaretha van der Deen, Hendrik Marks, Brigitte W M Willemse, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 18, 2014
Parametric methods for quantification of 18F-FAZA kinetics in non-small cell lung cancer patientsEline E Verwer, Idris Bahce, Floris H P van Velden, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 28, 2016
Accuracy and Precision of Partial-Volume Correction in Oncological PET/CT StudiesMatthijs C F Cysouw, Gerbrand Maria Kramer, Otto S Hoekstra, et al.
Lung Cancer (Amsterdam, Netherlands)|November 8, 2017
Continued use of afatinib with the addition of cetuximab after progression on afatinib in patients with EGFR mutation-positive non-small-cell lung cancer and acquired resistance to gefitinib or erlotinibLeora Horn, Scott Gettinger, D Ross Camidge, et al.
The European Respiratory Journal|January 25, 2008
Right ventricular contractility in systemic sclerosis-associated and idiopathic pulmonary arterial hypertensionM J Overbeek, J-W Lankhaar, N Westerhof, et al.
Pageof 70